Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share (APVO) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
APVO on Nasdaq
Shares outstanding
3,295,607
Price per share
$0.61
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
0
Total reported value
$0
Share change
-493,997
Value change
-$717,121
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share (APVO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
YA II PN, Ltd. 10% $1,663,965 357,842 YA II PN, Ltd. 16 Jun 2025
CVI Investments, Inc. 9.9% $1,073,526 357,842 CVI Investments, Inc. 30 Jun 2025
L1 Capital Global Opportunities Master Fund, Ltd. 5% -50% $492,900 -$362,100 164,300 -42% L1 Capital Global Opportunities Master Fund, Ltd. 14 Aug 2025
BANK OF AMERICA CORP /DE/ 0% -100% $125 -$715,879 86 -100% BANK OF AMERICA CORP /DE/ 31 Oct 2025

As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share (APVO). This represents 0% of the company’s total 3,295,607 outstanding shares.

Institutional Holders of Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share (APVO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$717,121 $0.61 0
2025 Q3 493,997 $717,121 +$709,654 $1.45 12
2025 Q2 5,035 $15,356 +$15,356 $3.02 6